Suppr超能文献

Influence of chronic dosing on theophylline clearance.

作者信息

Efthimiou H, Morgan D J, Ioannides-Demos L, Raymond K, McLean A J

出版信息

Br J Clin Pharmacol. 1984 May;17(5):525-30. doi: 10.1111/j.1365-2125.1984.tb02385.x.

Abstract

Theophylline clearance was studied in normal healthy volunteers before and after chronic oral dosing. Oral theophylline clearance showed a significant decrease (P less than 0.001) from 59.3 +/- 6.48 ml/min (mean +/- s.e. mean, n = 10) to 48.0 +/- 6.4 ml/min. Steady-state intravenous clearance decreased by 26 +/- 2% from 55.1 +/- 7.7 ml/min to 41.0 +/- 5.96 ml/min (mean +/- s.e. mean, n = 6; P less than 0.001) at constant steady-state intravenous test concentrations (mean 15.0 +/- 1.6 micrograms/ml after chronic oral dosing), excluding significant concentration dependence. Extrapolation of acute clearance findings to maintenance requirement may not be valid even in the same individual, with theophylline therapy requiring on-going review beyond acute stabilisation.

摘要

相似文献

1
Influence of chronic dosing on theophylline clearance.
Br J Clin Pharmacol. 1984 May;17(5):525-30. doi: 10.1111/j.1365-2125.1984.tb02385.x.
2
The interaction between i.v. theophylline and chronic oral dosing with slow release nifedipine in volunteers.
Br J Clin Pharmacol. 1986 Apr;21(4):389-92. doi: 10.1111/j.1365-2125.1986.tb05212.x.
3
Comparison of single and multiple dose pharmacokinetics of theophylline using stable isotopes.
Eur J Clin Pharmacol. 1986;30(1):113-20. doi: 10.1007/BF00614207.
6
Pharmacokinetic studies of theophylline in horses.
J Vet Pharmacol Ther. 1985 Mar;8(1):76-81. doi: 10.1111/j.1365-2885.1985.tb00927.x.
8
Pharmacokinetic properties of a new sustained-release theophylline preparation.
Int J Clin Pharmacol Ther Toxicol. 1983 Feb;21(2):69-72.
9
Lack of clinically important interaction between erythromycin and theophylline.
Eur J Clin Pharmacol. 1984;26(4):485-9. doi: 10.1007/BF00542146.

引用本文的文献

1
Influence of chronic dosing on theophylline clearance.
Br J Clin Pharmacol. 1985 May;19(5):713. doi: 10.1111/j.1365-2125.1985.tb02704.x.
2
Influence of chronic dosing on theophylline clearance.
Br J Clin Pharmacol. 1985 May;19(5):712-3. doi: 10.1111/j.1365-2125.1985.tb02703.x.
3
Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications.
Clin Pharmacokinet. 1985 Sep-Oct;10(5):432-42. doi: 10.2165/00003088-198510050-00005.
4
Comparison of single and multiple dose pharmacokinetics of theophylline using stable isotopes.
Eur J Clin Pharmacol. 1986;30(1):113-20. doi: 10.1007/BF00614207.

本文引用的文献

1
Serum level monitoring of a new slow release theophylline formulation in patients with chronic lung disease.
Br J Clin Pharmacol. 1980 Sep;10(3):265-71. doi: 10.1111/j.1365-2125.1980.tb01754.x.
2
Dose-dependent kinetics for theophylline: observations among ambulatory asthmatic children.
J Pediatr. 1980 Nov;97(5):825-8. doi: 10.1016/s0022-3476(80)80280-0.
3
Nonlinear theophylline elimination.
Clin Pharmacol Ther. 1982 Mar;31(3):358-69. doi: 10.1038/clpt.1982.46.
4
Dose-dependent pharmacokinetics with single daily dose slow release theophylline in patients with chronic lung disease.
Br J Clin Pharmacol. 1982 Feb;13(2):241-3. doi: 10.1111/j.1365-2125.1982.tb01368.x.
5
Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.
Clin Pharmacol Ther. 1972 May-Jun;13(3):349-60. doi: 10.1002/cpt1972133349.
7
Renal clearance of theophylline in man.
J Clin Pharmacol. 1976 Jul;16(7):329-32. doi: 10.1002/j.1552-4604.1976.tb01528.x.
8
Dose-dependent kinetics of theophylline disposition in asthmatic children.
J Pediatr. 1977 Nov;91(5):820-4. doi: 10.1016/s0022-3476(77)81051-2.
9
Aminophylline bioavailability and the across-time stability of plasma theophylline levels.
J Pediatr. 1977 Mar;90(3):473-6. doi: 10.1016/s0022-3476(77)80719-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验